Jasińska-Balwierz · Biology 2025 · Analytical chemistry / cross-sectional product screening · n=11 products

Heavy Metal Contamination in Adaptogenic Herbal Dietary Supplements: Experimental, Assessment and Regulatory Safety Perspectives.

Cited 6 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Laboratory analytical bench testing of commercial product samples without human subjects (by design analogy).

PubMed 41300272 · doi:10.3390/biology14111479 · record verified 2026-08-28

What was done

Researchers evaluated heavy metal contamination across 11 commercially available adaptogenic herbal supplements (tablets, powders, and dried materials) sold on the Polish market. The analyzed supplements contained Withania somnifera (ashwagandha), Rhodiola rosea, Panax ginseng, or Schisandra chinensis. Levels of lead (Pb), cadmium (Cd), mercury (Hg), nickel (Ni), and other elements were measured using flame atomic absorption spectroscopy (FAAS) and direct mercury analysis (AMA 254) and evaluated against international safety limits.

What was found

Widespread contamination was observed, primarily involving lead and nickel. In processed forms (tablets and dried fruits), lead concentrations exceeded permissible safety limits by up to 235%, while nickel concentrations exceeded limits by up to 321%. Preparations of Schisandra chinensis had the highest contamination levels among the tested herbs. Additionally, raw materials sourced from India had significantly higher nickel concentrations compared to those from China (p < 0.01). The abstract states that a majority of the tested supplements failed to meet toxicological safety criteria.

Why it matters

This study provides empirical evidence that commercially sold adaptogenic herbal supplements can carry substantial toxic heavy metal contamination exceeding international safety standards. It highlights a critical regulatory and quality control gap in the global herbal supplement supply chain.

Limits

The sample size was very small, with only 11 commercial products evaluated. The abstract does not report baseline absolute concentrations, batch-to-batch variability within brands, or specific brand names. Because this was a laboratory screening study, human bioavailability, clinical exposure, and health outcomes were not measured.

Cited by